Harandian Farnoush, Pham Donavan, Ben-Shoshan Moshe
a McGill University , Montreal , Canada.
b Department of Allergy & Immunology , McGill University Health Center, Montreal Children's Hospital , Montreal , Canada.
Postgrad Med. 2016 Aug;128(6):557-62. doi: 10.1080/00325481.2016.1191319. Epub 2016 Jun 6.
β-lactam antibiotics are the most widely used group of antibiotics, given their effectiveness for the most common bacterial pathogens and their relatively low price. Adverse reactions, mainly cutaneous, are often reported to be associated with their use and hence, less effective and usually more costly alternative antibiotics are prescribed. However, it is not clear what is the risk of immediate immune-mediated (i.e. developing within one hour of administration) and potentially life-threatening reactions among those using β-lactam antibiotic. We conducted a systematic review to assess the prevalence of immediate adverse reactions to β-lactam antibiotics, specifically penicillin derivatives, in patients with a reported adverse reaction to β-lactam antibiotics. In addition, we determined the effect of age on the prevalence of immediate reactions. Assessing the true risk of using β-lactam antibiotics in patients with a reported allergy could prevent physicians from unnecessarily discouraging the use of β-lactam antibiotics. We conducted a systematic review and a meta-analysis using the PubMed, OVID, and Embase databases of work published in English and in French in the last 5 years. Studies were only eligible if they established the prevalence of immediate penicillin reactions with skin testing or challenges in case of negative skin tests. The meta-analysis was conducted using Stata version 12.0. The prevalence of immediate reactions to penicillin derivatives in patients reporting a β-lactam hypersensitivity is 1.98% (95%CI; 1.35%, 2.60%) in the pediatric (under 18 years old) group, 7.78% (95%CI; 6.53%, 9.04%) in the adult group, and 2.84% (95%CI; 1.77%, 3.91%) in the combined group, as tested in various studies, using skin tests and oral challenges. The I(2) value ranged between 87.2% and 97.0%. Our results indicate that the prevalence of immediate reactions is higher in adults than in children. However, wide confidence intervals and a large study heterogeneity preclude conclusive estimates.
β-内酰胺类抗生素是使用最为广泛的一类抗生素,因其对最常见的细菌病原体有效且价格相对低廉。不良反应(主要为皮肤反应)常被报道与使用此类抗生素有关,因此,医生会开具效果欠佳且通常成本更高的替代抗生素。然而,使用β-内酰胺类抗生素的患者发生即刻免疫介导反应(即给药后一小时内出现)并可能危及生命的风险尚不清楚。我们进行了一项系统评价,以评估报告有β-内酰胺类抗生素不良反应的患者中,对β-内酰胺类抗生素,特别是青霉素衍生物的即刻不良反应的发生率。此外,我们还确定了年龄对即刻反应发生率的影响。评估报告有过敏反应的患者使用β-内酰胺类抗生素的真正风险,可防止医生不必要地不鼓励使用β-内酰胺类抗生素。我们使用PubMed、OVID和Embase数据库,对过去5年以英文和法文发表的研究进行了系统评价和荟萃分析。只有那些通过皮肤试验或皮肤试验阴性时进行激发试验确定了即刻青霉素反应发生率的研究才符合条件。荟萃分析使用的是Stata 12.0版软件。在各类研究中,通过皮肤试验和口服激发试验检测发现,报告有β-内酰胺类超敏反应的患者中,儿科(18岁以下)组对青霉素衍生物的即刻反应发生率为1.98%(95%置信区间:1.35%,2.60%),成人组为7.78%(95%置信区间:6.53%,9.04%),合并组为2.84%(95%置信区间:1.77%,3.91%)。I²值在87.2%至97.0%之间。我们的结果表明,成人即刻反应的发生率高于儿童。然而,较宽的置信区间和较大的研究异质性妨碍了得出确定性的估计。